Journal article

CD28-mediated co-stimulation: a quantitative support for TCR signalling.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Acuto, O., & Michel, F. (2003). CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nature Reviews. Immunology, 3(12), 939–951.

MLA Style

Acuto, O., and F. Michel. “CD28-Mediated Co-Stimulation: a Quantitative Support for TCR Signalling.” Nature Reviews. Immunology, vol. 3, no. 12, 2003, pp. 939–51.

Chicago Style

Acuto, O, and F Michel. 2003. “CD28-Mediated Co-Stimulation: a Quantitative Support for TCR Signalling.” Nature Reviews. Immunology 3 (12): 939–51.
Share
Print

Access Document

Publisher copy:: 10.1038/nri1248

Authors

+ Acuto, O More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Pathology Dunn School
Role:: Author

+ Michel, F More by this author

Role:: Author

Journal:: Nature reviews. Immunology More from this journal
Volume:: 3
Issue:: 12
Pages:: 939-951
Publication date:: 2003-12-01
DOI:: 10.1038/nri1248
EISSN:: 1474-1741
ISSN:: 1474-1733

Language:: English
Keywords:: Lymphocyte Activation

Carrier Proteins

Animals

Antigens, CD28

Adaptor Proteins, Signal Transducing

Cell Cycle

T-Lymphocytes

Membrane Proteins

Phosphoproteins

Signal Transduction

Mice

Humans

Phosphatidylinositol 3-Kinases
Pubs id:: pubs:8360
UUID:: uuid:dc0cfa23-b2ee-4010-ad1b-23763626f5eb
Local pid:: pubs:8360
Source identifiers:: 8360
Deposit date:: 2012-12-19

Terms of use

Copyright date:: 2003

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP